Mauritania documents

Annual progress reports

All eligible countries are invited to submit proposals for Gavi support. 

Annual progress report Mauritania 2009

Annual progress report Mauritania 2009 [Français]

Annual progress report Mauritania 2008

Annual progress report Mauritania 2008 [Français]

Annual progress report Mauritania 2007

Annual progress report Mauritania 2007 [Français]

Annual progress report Mauritania 2006

Annual progress report Mauritania 2004

Annual progress report Mauritania 2005

Annual progress report Mauritania 2003

Annual progress report Mauritania 2014

Annual progress report Mauritania 2003 [Français]

Annual progress report Mauritania 2014 [Français]

Annual progress report Mauritania 2004 [Français]

Annual progress report Mauritania 2013

Annual progress report Mauritania 2002

Annual progress report Mauritania 2013 [Français]

Annual progress report Mauritania 2012

Annual progress report Mauritania 2011

Approved proposals

All eligible countries are invited to submit proposals for Gavi support. 

Proposal for NVS - MR 1+2 dose routine 2020 : Mauritania

Date of Gavi approval: 21 August 2020

Proposal for NVS - HPV support 2018: Mauritania

Date of Gavi approval: 23 August 2018

Proposal for NVS - HPV support 2018: Mauritania [Français]

Date of Gavi approval: 23 August 2018

Proposal for CCEOP support 2018: Mauritania

Date of Gavi approval: 10 April 2018

Proposal for MR catch-up campaign and routine support 2017: Mauritania [Français]

Date of Gavi approval: 31 July 2017

Proposal for MR catch-up campaign and routine support 2017: Mauritania

Date of Gavi approval: 31 July 2017

Proposal for HSS support: Mauritania 2017

Date of Gavi approval: 29 May 2017

Proposal for HSS support: Mauritania 2017 [Français]

Date of Gavi approval: 29 May 2017

Proposal for HSS re-programming: Mauritania [Français]

Date of Gavi approval: 24 November 2016

Proposal for NVS - IPV support: Mauritania

Date of Gavi approval: 02 February 2015

Proposal for NVS - IPV support: Mauritania [Français]

Date of Gavi approval: 02 February 2015

Proposal for Men A, Rota Campaign support: Mauritania

Date of Gavi approval: 04 March 2014

Proposal for Men A, Rota Campaign support: Mauritania [Français]

Date of Gavi approval: 04 March 2014

Proposal for NVS - PCV support: Mauritania [Français]

Date of Gavi approval: 12 April 2012

Proposal for NVS - PCV support: Mauritania

Date of Gavi approval: 12 April 2012

Proposal for HSS support: Mauritania

Date of Gavi approval: 29 July 2010

Proposal for HSS support: Mauritania [Français]

Date of Gavi approval: 29 July 2010

Proposal for NVS - Penta support: Mauritania

Date of Gavi approval: 28 July 2008

Proposal for NVS - Penta support: Mauritania [Français]

Date of Gavi approval: 24 July 2008

Proposal for NVS - Hep B extension support: Mauritania

Date of Gavi approval: 01 June 2004

Proposal for NVS - Hep B extension support: Mauritania [Français]

Date of Gavi approval: 01 June 2004

Proposal for ISS support: Mauritania

Date of Gavi approval: 01 November 2002

Proposal for INS support: Mauritania

Date of Gavi approval: 01 May 2002

Proposal for INS support: Mauritania [Français]

Date of Gavi approval: 01 May 2002

Comprehensive multi-year plans/Financial sustainability plans

The comprehensive multi-year plan (cMYP) is a single plan which consolidates several immunisation activities. It is a key planning and management tool for national immunisation programmes. It addresses global, national, and subnational immunisation objectives and strategies, and evaluates the costs and financing of the programme in line with the WHO-UNICEF Global Immunization Vision and Strategy 2006-2015. Gavi requires countries to submit a cMYP along with the standard proposal form when applying for Gavi support (ISS, INS, and NVS). In 2006, over 50 countries had developed cMYPs using the WHO-UNICEF cMYP guidelines and costing tool.
The cMYP replaces the financial sustainability plan (FSP), used to assess the funding challenges of a country's national immunisation programme within the broader health financing context and to describe the government’s approach to mobilising and effectively using resources to support medium- and long-term immunisation objectives. 

Comprehensive multi-year plan for 2012-2015

Country co-financing information sheet

The country-specific co-financing sheets provide up-to-date information on countries’ eligibility status, co-financing fulfilment and requirements. They also give a summary of government health expenditure, including immunisation financing.

Specifically, the sheets provide a history of the Gavi-supported vaccines introduced per country, the country’s co-financing payments to date and its co-financing requirements for the current year. In case the country has defaulted on its co-financing requirements, there is an overview of the co-financing arrears of the previous year. Finally, the sheets provide co-financing projections for the next five years based on our latest forecasts.

The information sheets are updated at least twice per year to account for new information on countries’ co-financing fulfilment (in the first quarter) and eligibility status (in the third quarter).

Co-financing information sheet French

Co-financing information sheet Mauritania

Decision Letters and Partnerships Agreement

The Decision Letter or Partnership Framework Agreement provides a summary of the details of the new approval or continuation of a Gavi window of support, following the independent review of a new application or annual progress report submitted by a country.

Lettre de décision SVN Mauritanie 2012

Lettre de Décision CCEOP Mauritanie 2018 (French)

Lettre de décision SVN Mauritanie 2015

Lettre de décision SVN Mauritanie 2014(2)

Lettre de décision SVN Mauritanie 2014

Lettre de decision SVN Mauritanie 2013 (2)

Lettre de décision SVN Mauritanie 2013

COVAX Technical Assistance Plans

In September 2020, the Gavi Board approved resources from core funding to focus on urgent technical assistance (TA) needs for 92 AMC economies, for the planning and preparation for the introduction of the COVID-19 vaccine. The plan includes sets of activities, milestones and budget for a given year.

COVAX Technical Assistance Plan Mauritania 2021

Targeted country assistance plans

Targeted country assistance (TCA) are resources provided to in-country partners under Gavi’s partners’ engagement framework (PEF). A country’s TCA plan is based on needs expressed by the country during the joint appraisal discussions. It includes sets of activities, milestones and budget for a given year.

Targeted Country Assistance Plan Mauritania 2021

Targeted Country Assistance Plan Mauritania 2020

Targeted Country Assistance Plan Mauritania 2019

Targeted country assistance plan Mauritania 2018 [French]

Targeted country assistance plan Mauritania 2017 [French]

The joint appraisal report

The joint appraisal is an in-country, multi-stakeholder review of the implementation progress and performance of Gavi's vaccine and cash grant support to the country, and of its contribution to improved immunisation outcomes. The outcome of the appraisal is the completed "joint appraisal report" that captures Gavi grant performance as well as implementation challenges. The joint appraisal report informs discussions with national coordination mechanisms on areas where greater national investments and efforts, as well as technical support, are needed.

Joint Appraisal Mauritania 2019

Joint Appraisal Mauritania 2018

Joint Appraisal Mauritania 2017 [French]

Joint Appraisal Mauritania 2018 [French]

Joint Appraisal Mauritania 2016 [French]

Joint Appraisal Mauritania 2015 [French]

Joint Appraisal Mauritania 2014 [French]

Subscribe to our newsletter